Brief: Grand Pharmaceutical Obtained Exclusive Development & Commercialization Rights Of Product
11/12/2024 11:26
Dec 11 (Reuters) - Grand Pharmaceutical Group 0512.HK :
* OBTAINED EXCLUSIVE DEVELOPMENT & COMMERCIALIZATION RIGHTS
OF
PRODUCT FOR TREATMENT OF DRY EYE
Further company coverage: 0512.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grand Pharmaceutical
See all newsBrief: Grand Pharmaceutical Group Declares No Interim Dividend Has Been Paid
Grand Pharmaceutical H1 revenue rises on nuclear medicine demand
Grand Pharma rises most in over a year as drug gets US FDA fast track designation
GPN01530-2 Granted Fast Track Designation By FDA
Brief: Grand Pharmaceutical Group Enters Huadong Medicine Supply Agreement